Prostate cancer originates in the male prostate gland and has become one of the most common types of cancer. It typically remains confined in this region, however it may spread to other locations throughout the body. Risk of prostate cancer increases with age, family history, obesity, and ethnicity as black males are the most likely to develop prostate cancer. Treatment for prostate cancer includes radiation therapy, hormone therapy, surgery, and chemotherapy. Metastatic prostate cancer is diagnosed with the cancer has spread beyond the prostate gland to distant lymph nodes, bones, organs or tissues. Metastatic prostate cancer is considered an advanced form of this cancer, and there are no treatments to cure this form. However, various techniques for assisting in symptom relief and regulating the cancer spreading have surfaced over the last few years.
Metastatic Prostate Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Metastatic Prostate Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 2172 products for the study of Metastatic Prostate Cancer that can be applied to Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.